Table of Content

1 Report Overview
1.1 Celiac Disease Drug Definition
1.2 Market by Type
1.2.1 Global Celiac Disease Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Celiac Disease Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 First Line of Treatment
1.3.3 Second Line of Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Celiac Disease Drug Sales
2.1 Global Celiac Disease Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Celiac Disease Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Celiac Disease Drug Revenue by Region
2.3.1 Global Celiac Disease Drug Revenue by Region (2018-2023)
2.3.2 Global Celiac Disease Drug Revenue by Region (2024-2034)
2.4 Global Celiac Disease Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Celiac Disease Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Celiac Disease Drug Sales Quantity by Region
2.6.1 Global Celiac Disease Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Celiac Disease Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Celiac Disease Drug Sales Quantity by Manufacturers
3.1.1 Global Celiac Disease Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Celiac Disease Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Celiac Disease Drug Sales in 2024
3.2 Global Celiac Disease Drug Revenue by Manufacturers
3.2.1 Global Celiac Disease Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Celiac Disease Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Celiac Disease Drug Revenue in 2024
3.3 Global Celiac Disease Drug Sales Price by Manufacturers
3.4 Global Key Players of Celiac Disease Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Celiac Disease Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Celiac Disease Drug, Product Offered and Application
3.8 Global Key Manufacturers of Celiac Disease Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Celiac Disease Drug Sales Quantity by Type
4.1.1 Global Celiac Disease Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Celiac Disease Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Celiac Disease Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Celiac Disease Drug Revenue by Type
4.2.1 Global Celiac Disease Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Celiac Disease Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Celiac Disease Drug Revenue Market Share by Type (2018-2034)
4.3 Global Celiac Disease Drug Price by Type
4.3.1 Global Celiac Disease Drug Price by Type (2018-2023)
4.3.2 Global Celiac Disease Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Celiac Disease Drug Sales Quantity by Application
5.1.1 Global Celiac Disease Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Celiac Disease Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Celiac Disease Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Celiac Disease Drug Revenue by Application
5.2.1 Global Celiac Disease Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Celiac Disease Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Celiac Disease Drug Revenue Market Share by Application (2018-2034)
5.3 Global Celiac Disease Drug Price by Application
5.3.1 Global Celiac Disease Drug Price by Application (2018-2023)
5.3.2 Global Celiac Disease Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Celiac Disease Drug Sales by Company
6.1.1 North America Celiac Disease Drug Revenue by Company (2018-2023)
6.1.2 North America Celiac Disease Drug Sales Quantity by Company (2018-2023)
6.2 North America Celiac Disease Drug Market Size by Type
6.2.1 North America Celiac Disease Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Celiac Disease Drug Revenue by Type (2018-2034)
6.3 North America Celiac Disease Drug Market Size by Application
6.3.1 North America Celiac Disease Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Celiac Disease Drug Revenue by Application (2018-2034)
6.4 North America Celiac Disease Drug Market Size by Country
6.4.1 North America Celiac Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Celiac Disease Drug Revenue by Country (2018-2034)
6.4.3 North America Celiac Disease Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Celiac Disease Drug Sales by Company
7.1.1 Europe Celiac Disease Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Celiac Disease Drug Revenue by Company (2018-2023)
7.2 Europe Celiac Disease Drug Market Size by Type
7.2.1 Europe Celiac Disease Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Celiac Disease Drug Revenue by Type (2018-2034)
7.3 Europe Celiac Disease Drug Market Size by Application
7.3.1 Europe Celiac Disease Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Celiac Disease Drug Revenue by Application (2018-2034)
7.4 Europe Celiac Disease Drug Market Size by Country
7.4.1 Europe Celiac Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Celiac Disease Drug Revenue by Country (2018-2034)
7.4.3 Europe Celiac Disease Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Celiac Disease Drug Sales by Company
8.1.1 China Celiac Disease Drug Sales Quantity by Company (2018-2023)
8.1.2 China Celiac Disease Drug Revenue by Company (2018-2023)
8.2 China Celiac Disease Drug Market Size by Type
8.2.1 China Celiac Disease Drug Sales Quantity by Type (2018-2034)
8.2.2 China Celiac Disease Drug Revenue by Type (2018-2034)
8.3 China Celiac Disease Drug Market Size by Application
8.3.1 China Celiac Disease Drug Sales Quantity by Application (2018-2034)
8.3.2 China Celiac Disease Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Celiac Disease Drug Sales by Company
9.1.1 APAC Celiac Disease Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Celiac Disease Drug Revenue by Company (2018-2023)
9.2 APAC Celiac Disease Drug Market Size by Type
9.2.1 APAC Celiac Disease Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Celiac Disease Drug Revenue by Type (2018-2034)
9.3 APAC Celiac Disease Drug Market Size by Application
9.3.1 APAC Celiac Disease Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Celiac Disease Drug Revenue by Application (2018-2034)
9.4 APAC Celiac Disease Drug Market Size by Region
9.4.1 APAC Celiac Disease Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Celiac Disease Drug Revenue by Region (2018-2034)
9.4.3 APAC Celiac Disease Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Celiac Disease Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Celiac Disease Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Celiac Disease Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Celiac Disease Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Celiac Disease Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Celiac Disease Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Celiac Disease Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Celiac Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Celiac Disease Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 F. Hoffmann-La Roche Celiac Disease Drug Products and Services
11.1.5 F. Hoffmann-La Roche Celiac Disease Drug SWOT Analysis
11.1.6 F. Hoffmann-La Roche Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Johnson & Johnson Celiac Disease Drug Products and Services
11.2.5 Johnson & Johnson Celiac Disease Drug SWOT Analysis
11.2.6 Johnson & Johnson Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Merck Celiac Disease Drug Products and Services
11.3.5 Merck Celiac Disease Drug SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Pfizer Celiac Disease Drug Products and Services
11.4.5 Pfizer Celiac Disease Drug SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 ADMA Biologics
11.5.1 ADMA Biologics Company Information
11.5.2 ADMA Biologics Overview
11.5.3 ADMA Biologics Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 ADMA Biologics Celiac Disease Drug Products and Services
11.5.5 ADMA Biologics Celiac Disease Drug SWOT Analysis
11.5.6 ADMA Biologics Recent Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Overview
11.6.3 Amgen Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Amgen Celiac Disease Drug Products and Services
11.6.5 Amgen Celiac Disease Drug SWOT Analysis
11.6.6 Amgen Recent Developments
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Company Information
11.7.2 Anthera Pharmaceuticals Overview
11.7.3 Anthera Pharmaceuticals Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Anthera Pharmaceuticals Celiac Disease Drug Products and Services
11.7.5 Anthera Pharmaceuticals Celiac Disease Drug SWOT Analysis
11.7.6 Anthera Pharmaceuticals Recent Developments
11.8 Bayer
11.8.1 Bayer Company Information
11.8.2 Bayer Overview
11.8.3 Bayer Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Bayer Celiac Disease Drug Products and Services
11.8.5 Bayer Celiac Disease Drug SWOT Analysis
11.8.6 Bayer Recent Developments
11.9 Biogen
11.9.1 Biogen Company Information
11.9.2 Biogen Overview
11.9.3 Biogen Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Biogen Celiac Disease Drug Products and Services
11.9.5 Biogen Celiac Disease Drug SWOT Analysis
11.9.6 Biogen Recent Developments
11.10 BioLineRx
11.10.1 BioLineRx Company Information
11.10.2 BioLineRx Overview
11.10.3 BioLineRx Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 BioLineRx Celiac Disease Drug Products and Services
11.10.5 BioLineRx Celiac Disease Drug SWOT Analysis
11.10.6 BioLineRx Recent Developments
11.11 Biotest
11.11.1 Biotest Company Information
11.11.2 Biotest Overview
11.11.3 Biotest Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Biotest Celiac Disease Drug Products and Services
11.11.5 Biotest Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Information
11.12.2 Bristol-Myers Squibb Overview
11.12.3 Bristol-Myers Squibb Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Bristol-Myers Squibb Celiac Disease Drug Products and Services
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Celgene
11.13.1 Celgene Company Information
11.13.2 Celgene Overview
11.13.3 Celgene Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Celgene Celiac Disease Drug Products and Services
11.13.5 Celgene Recent Developments
11.14 Takeda Pharmaceutical
11.14.1 Takeda Pharmaceutical Company Information
11.14.2 Takeda Pharmaceutical Overview
11.14.3 Takeda Pharmaceutical Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Takeda Pharmaceutical Celiac Disease Drug Products and Services
11.14.5 Takeda Pharmaceutical Recent Developments
11.15 Novartis
11.15.1 Novartis Company Information
11.15.2 Novartis Overview
11.15.3 Novartis Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 Novartis Celiac Disease Drug Products and Services
11.15.5 Novartis Recent Developments
11.16 LFB Group
11.16.1 LFB Group Company Information
11.16.2 LFB Group Overview
11.16.3 LFB Group Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 LFB Group Celiac Disease Drug Products and Services
11.16.5 LFB Group Recent Developments
11.17 Kedrion Biopharma
11.17.1 Kedrion Biopharma Company Information
11.17.2 Kedrion Biopharma Overview
11.17.3 Kedrion Biopharma Celiac Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.17.4 Kedrion Biopharma Celiac Disease Drug Products and Services
11.17.5 Kedrion Biopharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Celiac Disease Drug Value Chain Analysis
12.2 Celiac Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Celiac Disease Drug Production Mode & Process
12.4 Celiac Disease Drug Sales and Marketing
12.4.1 Celiac Disease Drug Sales Channels
12.4.2 Celiac Disease Drug Distributors
12.5 Celiac Disease Drug Customers
13 Market Dynamics
13.1 Celiac Disease Drug Industry Trends
13.2 Celiac Disease Drug Market Drivers
13.3 Celiac Disease Drug Market Challenges
13.4 Celiac Disease Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Celiac Disease Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Distension
Table 3. Major Manufacturers of Diarrhea
Table 4. Major Manufacturers of Anorexia
Table 5. Major Manufacturers of Others
Table 6. Global Celiac Disease Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Celiac Disease Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Celiac Disease Drug Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Celiac Disease Drug Revenue Market Share by Region (2018-2023)
Table 10. Global Celiac Disease Drug Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Celiac Disease Drug Revenue Market Share by Region (2024-2034)
Table 12. Global Celiac Disease Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 13. Global Celiac Disease Drug Sales by Region (2018-2023) & (K Pcs)
Table 14. Global Celiac Disease Drug Sales Market Share by Region (2018-2023)
Table 15. Global Celiac Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 16. Global Celiac Disease Drug Sales Market Share by Region (2024-2034)
Table 17. Global Celiac Disease Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 18. Global Celiac Disease Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Celiac Disease Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Celiac Disease Drug Revenue Share by Manufacturers (2018-2023)
Table 21. Global Celiac Disease Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 22. Global Key Players of Celiac Disease Drug, Industry Ranking, 2021 VS 2024
Table 23. Global Celiac Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Celiac Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease Drug as of 2024)
Table 25. Global Key Manufacturers of Celiac Disease Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Celiac Disease Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Celiac Disease Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Celiac Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 30. Global Celiac Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global Celiac Disease Drug Sales Quantity Share by Type (2018-2023)
Table 32. Global Celiac Disease Drug Sales Quantity Share by Type (2024-2034)
Table 33. Global Celiac Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Celiac Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Celiac Disease Drug Revenue Share by Type (2018-2023)
Table 36. Global Celiac Disease Drug Revenue Share by Type (2024-2034)
Table 37. Celiac Disease Drug Price by Type (2018-2023) & (USD/Pcs)
Table 38. Global Celiac Disease Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global Celiac Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 40. Global Celiac Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global Celiac Disease Drug Sales Quantity Share by Application (2018-2023)
Table 42. Global Celiac Disease Drug Sales Quantity Share by Application (2024-2034)
Table 43. Global Celiac Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Celiac Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Celiac Disease Drug Revenue Share by Application (2018-2023)
Table 46. Global Celiac Disease Drug Revenue Share by Application (2024-2034)
Table 47. Celiac Disease Drug Price by Application (2018-2023) & (USD/Pcs)
Table 48. Global Celiac Disease Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America Celiac Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Celiac Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 51. North America Celiac Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 52. North America Celiac Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America Celiac Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Celiac Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Celiac Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 56. North America Celiac Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America Celiac Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Celiac Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Celiac Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Celiac Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Celiac Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Celiac Disease Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 63. North America Celiac Disease Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe Celiac Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 65. Europe Celiac Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Celiac Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 67. Europe Celiac Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe Celiac Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Celiac Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Celiac Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 71. Europe Celiac Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe Celiac Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Celiac Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Celiac Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Celiac Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Celiac Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Celiac Disease Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 78. Europe Celiac Disease Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China Celiac Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 80. China Celiac Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Celiac Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 82. China Celiac Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China Celiac Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Celiac Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Celiac Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 86. China Celiac Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China Celiac Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Celiac Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Celiac Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 90. APAC Celiac Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Celiac Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 92. APAC Celiac Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC Celiac Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Celiac Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Celiac Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 96. APAC Celiac Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC Celiac Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Celiac Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Celiac Disease Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Celiac Disease Drug Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Celiac Disease Drug Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Celiac Disease Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 103. APAC Celiac Disease Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 105. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 111. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Celiac Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 118. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. F. Hoffmann-La Roche Company Information
Table 120. F. Hoffmann-La Roche Description and Overview
Table 121. F. Hoffmann-La Roche Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 122. F. Hoffmann-La Roche Celiac Disease Drug Product and Services
Table 123. F. Hoffmann-La Roche Celiac Disease Drug SWOT Analysis
Table 124. F. Hoffmann-La Roche Recent Developments
Table 125. Johnson & Johnson Company Information
Table 126. Johnson & Johnson Description and Overview
Table 127. Johnson & Johnson Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Johnson & Johnson Celiac Disease Drug Product and Services
Table 129. Johnson & Johnson Celiac Disease Drug SWOT Analysis
Table 130. Johnson & Johnson Recent Developments
Table 131. Merck Company Information
Table 132. Merck Description and Overview
Table 133. Merck Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 134. Merck Celiac Disease Drug Product and Services
Table 135. Merck Celiac Disease Drug SWOT Analysis
Table 136. Merck Recent Developments
Table 137. Pfizer Company Information
Table 138. Pfizer Description and Overview
Table 139. Pfizer Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Pfizer Celiac Disease Drug Product and Services
Table 141. Pfizer Celiac Disease Drug SWOT Analysis
Table 142. Pfizer Recent Developments
Table 143. ADMA Biologics Company Information
Table 144. ADMA Biologics Description and Overview
Table 145. ADMA Biologics Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 146. ADMA Biologics Celiac Disease Drug Product and Services
Table 147. ADMA Biologics Celiac Disease Drug SWOT Analysis
Table 148. ADMA Biologics Recent Developments
Table 149. Amgen Company Information
Table 150. Amgen Description and Overview
Table 151. Amgen Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 152. Amgen Celiac Disease Drug Product and Services
Table 153. Amgen Celiac Disease Drug SWOT Analysis
Table 154. Amgen Recent Developments
Table 155. Anthera Pharmaceuticals Company Information
Table 156. Anthera Pharmaceuticals Description and Overview
Table 157. Anthera Pharmaceuticals Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 158. Anthera Pharmaceuticals Celiac Disease Drug Product and Services
Table 159. Anthera Pharmaceuticals Celiac Disease Drug SWOT Analysis
Table 160. Anthera Pharmaceuticals Recent Developments
Table 161. Bayer Company Information
Table 162. Bayer Description and Overview
Table 163. Bayer Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 164. Bayer Celiac Disease Drug Product and Services
Table 165. Bayer Celiac Disease Drug SWOT Analysis
Table 166. Bayer Recent Developments
Table 167. Biogen Company Information
Table 168. Biogen Description and Overview
Table 169. Biogen Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 170. Biogen Celiac Disease Drug Product and Services
Table 171. Biogen Celiac Disease Drug SWOT Analysis
Table 172. Biogen Recent Developments
Table 173. BioLineRx Company Information
Table 174. BioLineRx Description and Overview
Table 175. BioLineRx Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 176. BioLineRx Celiac Disease Drug Product and Services
Table 177. BioLineRx Celiac Disease Drug SWOT Analysis
Table 178. BioLineRx Recent Developments
Table 179. Biotest Company Information
Table 180. Biotest Description and Overview
Table 181. Biotest Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 182. Biotest Celiac Disease Drug Product and Services
Table 183. Biotest Recent Developments
Table 184. Bristol-Myers Squibb Company Information
Table 185. Bristol-Myers Squibb Description and Overview
Table 186. Bristol-Myers Squibb Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 187. Bristol-Myers Squibb Celiac Disease Drug Product and Services
Table 188. Bristol-Myers Squibb Recent Developments
Table 189. Celgene Company Information
Table 190. Celgene Description and Overview
Table 191. Celgene Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 192. Celgene Celiac Disease Drug Product and Services
Table 193. Celgene Recent Developments
Table 194. Takeda Pharmaceutical Company Information
Table 195. Takeda Pharmaceutical Description and Overview
Table 196. Takeda Pharmaceutical Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 197. Takeda Pharmaceutical Celiac Disease Drug Product and Services
Table 198. Takeda Pharmaceutical Recent Developments
Table 199. Novartis Company Information
Table 200. Novartis Description and Overview
Table 201. Novartis Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 202. Novartis Celiac Disease Drug Product and Services
Table 203. Novartis Recent Developments
Table 204. LFB Group Company Information
Table 205. LFB Group Description and Overview
Table 206. LFB Group Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 207. LFB Group Celiac Disease Drug Product and Services
Table 208. LFB Group Recent Developments
Table 209. Kedrion Biopharma Company Information
Table 210. Kedrion Biopharma Description and Overview
Table 211. Kedrion Biopharma Celiac Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 212. Kedrion Biopharma Celiac Disease Drug Product and Services
Table 213. Kedrion Biopharma Recent Developments
Table 214. Key Raw Materials Lists
Table 215. Raw Materials Key Suppliers Lists
Table 216. Celiac Disease Drug Distributors List
Table 217. Celiac Disease Drug Customers List
Table 218. Celiac Disease Drug Market Trends
Table 219. Celiac Disease Drug Market Drivers
Table 220. Celiac Disease Drug Market Challenges
Table 221. Celiac Disease Drug Market Restraints
Table 222. Research Programs/Design for This Report
Table 223. Key Data Information from Secondary Sources
Table 224. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Disease Drug Product Picture
Figure 2. Global Celiac Disease Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Celiac Disease Drug Market Share by Type in 2024 & 2034
Figure 4. Distension Product Picture
Figure 5. Diarrhea Product Picture
Figure 6. Anorexia Product Picture
Figure 7. Others Product Picture
Figure 8. Global Celiac Disease Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Celiac Disease Drug Market Share by Application in 2024 & 2034
Figure 10. First Line of Treatment
Figure 11. Second Line of Treatment
Figure 12. Celiac Disease Drug Report Years Considered
Figure 13. Global Celiac Disease Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Celiac Disease Drug Revenue 2018-2034 (US$ Million)
Figure 15. Global Celiac Disease Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Celiac Disease Drug Sales Quantity 2018-2034 (K Pcs)
Figure 17. Global Celiac Disease Drug Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Celiac Disease Drug Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Celiac Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 20. North America Celiac Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Celiac Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. Europe Celiac Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Celiac Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. China Celiac Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Celiac Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. APAC Celiac Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. Middle East, Africa and Latin America Celiac Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Celiac Disease Drug Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Celiac Disease Drug Revenue in 2024
Figure 31. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Celiac Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Celiac Disease Drug Revenue Market Share by Type (2018-2034)
Figure 34. Global Celiac Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Celiac Disease Drug Revenue Market Share by Application (2018-2034)
Figure 36. North America Celiac Disease Drug Revenue Market Share by Company in 2024
Figure 37. North America Celiac Disease Drug Sales Quantity Market Share by Company in 2024
Figure 38. North America Celiac Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Celiac Disease Drug Revenue Market Share by Type (2018-2034)
Figure 40. North America Celiac Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Celiac Disease Drug Revenue Market Share by Application (2018-2034)
Figure 42. North America Celiac Disease Drug Revenue Share by Country (2018-2034)
Figure 43. North America Celiac Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Celiac Disease Drug Sales Quantity Market Share by Company in 2024
Figure 47. Europe Celiac Disease Drug Revenue Market Share by Company in 2024
Figure 48. Europe Celiac Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Celiac Disease Drug Revenue Market Share by Type (2018-2034)
Figure 50. Europe Celiac Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Celiac Disease Drug Revenue Market Share by Application (2018-2034)
Figure 52. Europe Celiac Disease Drug Revenue Share by Country (2018-2034)
Figure 53. Europe Celiac Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 55. France Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 59. China Celiac Disease Drug Sales Quantity Market Share by Company in 2024
Figure 60. China Celiac Disease Drug Revenue Market Share by Company in 2024
Figure 61. China Celiac Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Celiac Disease Drug Revenue Market Share by Type (2018-2034)
Figure 63. China Celiac Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Celiac Disease Drug Revenue Market Share by Application (2018-2034)
Figure 65. APAC Celiac Disease Drug Sales Quantity Market Share by Company in 2024
Figure 66. APAC Celiac Disease Drug Revenue Market Share by Company in 2024
Figure 67. APAC Celiac Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Celiac Disease Drug Revenue Market Share by Type (2018-2034)
Figure 69. APAC Celiac Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Celiac Disease Drug Revenue Market Share by Application (2018-2034)
Figure 71. APAC Celiac Disease Drug Revenue Share by Region (2018-2034)
Figure 72. APAC Celiac Disease Drug Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 77. India Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Celiac Disease Drug Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Celiac Disease Drug Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Celiac Disease Drug Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Celiac Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Celiac Disease Drug Revenue Share by Country (2018-2034)
Figure 86. Brazil Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Celiac Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Celiac Disease Drug Value Chain
Figure 92. Celiac Disease Drug Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed